ACE2 and COVID-19: As such, the CVS is targeted both directly (through viral damage to myocardial cells) and indirectly (through immune cell activation and ACE-2 downregulation), leading patients who suffer from CVS diseases or diabetes to having susceptibility to a more severe form of COVID-19 [1,18,19].